CN110373390A - A kind of construction method of xenotransplant basis donor pig - Google Patents
A kind of construction method of xenotransplant basis donor pig Download PDFInfo
- Publication number
- CN110373390A CN110373390A CN201910497791.6A CN201910497791A CN110373390A CN 110373390 A CN110373390 A CN 110373390A CN 201910497791 A CN201910497791 A CN 201910497791A CN 110373390 A CN110373390 A CN 110373390A
- Authority
- CN
- China
- Prior art keywords
- pig
- basis
- gene
- xenotransplant
- donor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K67/00—Rearing or breeding animals, not otherwise provided for; New breeds of animals
- A01K67/027—New breeds of vertebrates
- A01K67/0271—Chimeric animals, e.g. comprising exogenous cells
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70596—Molecules with a "CD"-designation not provided for elsewhere
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
- C12N15/873—Techniques for producing new embryos, e.g. nuclear transfer, manipulation of totipotent cells or production of chimeric embryos
- C12N15/877—Techniques for producing new mammalian cloned embryos
- C12N15/8778—Swine embryos
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2207/00—Modified animals
- A01K2207/12—Animals modified by administration of exogenous cells
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2227/00—Animals characterised by species
- A01K2227/10—Mammal
- A01K2227/108—Swine
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2267/00—Animals characterised by purpose
- A01K2267/02—Animal zootechnically ameliorated
- A01K2267/025—Animal producing cells or organs for transplantation
Abstract
The present invention relates to a kind of construction methods of xenotransplant basis donor pig, belong to Animal Biotechnology field.On the basis of fetal fibroblast, tri- genes of GGTA1, CMAH, B4GalNT2 are knocked out using CRISPR/Cas9 gene editing technology, and insertion tri- humanization modifiers of hCD55, hCD59, hCD46 are pinpointed, in conjunction with the xenotransplantation donors basis pig of somatic cell nuclear transfer technique building GTKO/CMAHKO/B4GalNT2KO/hCD55/hCD59/hCD46 genes modification.The present invention solves the common problem that antigen-antibody immunological rejection present in xenotransplant and complement are adjusted to a certain extent, it is suitble to the building of the xenotransplant donor pig of the tissue specificities such as organs and pancreas islet, skin such as heart, kidney, liver to lay a good foundation to research and develop on the basis of basic donor pig, there is important application value and application prospect to the xenotransplantation donors pig of building genes modification.
Description
Technical field
The invention belongs to Animal Biotechnology fields, specifically, being related to a kind of xenotransplant basis donor pig
Construction method.
Background technique
Organ transplant is to treat the unique channel of terminal phase organ failure patient, and heterograft is to solve human organ to supply
The most effective approach of body critical shortage.In recent years, with China's diabetes, chronic kidney disease, cardiovascular disease and hepatitis etc.
Patients with chronic diseases increases substantially, so that the patient for developing into the organ failures such as terminal phase liver, kidney, the heart sharply increases
Add, it also will be increasing to the pressure of organ demand.According to incompletely statistics, clinical organ transplant can be implemented in China every year at present
Quantity be about 10,000, and wait the patient of organ transplant then to have 1,500,000, wait organ transplant and organ transplant trouble can be carried out
The quantity ratio of person has reached 150:1.Moreover, China stopped using convict sentenced to death's organ as donor from 2015 comprehensively
Body source, the final source that can only use the organ that citizen voluntarily contributes after dead as China's organ transplant, this certainly will lead
Causing organ donor, originally the situation of worsening shortages is more acute, this is for the huge PATIENT POPULATION that the whole nation waits donor, extremely
The organ that person contributes seriously is unable to meet demand.Therefore, new transplantation donor is found to solve current organ critical shortage
Problem is very urgent.
Speak of xenotransplant, pig is easy to captive breeding, and organ size matches with the mankind, physiology and metabolism aspect with
A possibility that mankind are extremely close, and people pig is total to illness generation is smaller, it is few to be related to dispute of ethic, and can enhance by gene modification
The matching of donor organ.Therefore, it is to be most suitable for the species as xenotransplantation donors that pig, which is recognized,.By nearly over half a century
Effort and exploration, screened at present nearly 30 can be effectively relieved immunology incompatibility to overcome the related of functional disorder
Gene.The donor pig of several genes modification is also developed and has carried out pig and tested to the heterograft of non-human primates.
Although pig is approved as the source of human organ transplantation, transplanting pathogenic microorganism infection risk is immunized
It is serious difficult and critical that incompatibility and functional disorder three major issues face pig as xenotransplant
Challenge is also not enough to convert to clinical medicine.For this purpose, a kind of building of xenotransplant basal gene modification pig will be xenogenesis
New approach is opened up in organ transplant research, and boosting transplanting achieves initial success, and such as knocks out α -1,3- galactoside transferase
(GGTA1) gene can avoid Hyperacute immunological rejection, and knocking out porcine endogenous retrovirus (PERVs) gene can keep away
The cross-species infection for exempting from virus, solves the problems, such as the bio-safety of heterograft, but the immunology incompatibility after heterograft
It more needs to pay close attention to functional disorder.Therefore, a kind of building of xenotransplant basis donor pig will be to development Xenogeneic organ
The research and extension application of transplanting has great importance.
Summary of the invention
In view of the above problems, the present invention provides a kind of construction method of xenotransplant basis donor pig, this method
For xenotransplant, there are the common problems such as immunology incompatibility and functional disorder, construct GTKO/CMAHKO/
The heterograft basis donor pig of six gene modification of B4GalNT2KO/hCD55/hCD59/hCD46, will be really effective for exploitation
It is suitble to the donor pig of various organ xenotransplantations to lay a good foundation.
In order to achieve the above objectives, the invention provides the following technical scheme:
A kind of construction method of xenotransplant basis donor pig, specific steps are as follows:
1) it is fastened in pig fibroblast while knocking out GGTA1, CMAH, B4GalNT2 gene
On the basis of pig fibroblast, using CRISPR/Cas9 gene editing technology knock out GGTA1, CMAH,
Tri- genes of B4GalNT2 obtain the pig fibroblast of tri- gene knockout of GTKO/CMAHKO/B4GalNT2KO;
2) GTKO/CMAHKO/B4GalNT2KO modification pig fibroblast fasten pinpoint again insertion hCD55, hCD59,
Tri- humanization modifiers of hCD46
On the basis of tri- gene modification of GTKO/CMAHKO/B4GalNT2KO, then pinpoint insertion hCD55, hCD59, hCD46 tri-
A humanization modifier obtains the pig of GTKO/CMAHKO/B4GalNT2KO/hCD55/hCD59/hCD46 gene modification into fibre
Tie up cell line;
3) body-cell neucleus transplanting and embryo transfer
Using somatic cell nuclear transfer technique, the GTKO/CMAHKO/B4GalNT2KO/hCD55/hCD59/hCD46 that screening is obtained
Six gene cell systems carry out body-cell neucleus transplanting, and the modification situation of fetus identification gene is taken out when gestation, is separately cultured foundation
Six gene modification xenotransplantation donors pig fibroblasts, or it is basic to xenotransplant is obtained when being born when development of fetus
Donor pig individual;
4) continuous clone technology is utilized, by the heterograft basis donor pig fetus of six gene modifications of above-mentioned acquisition at fiber finer
Born of the same parents are to carry out body-cell neucleus transplanting and embryo transfer, and batch obtains xenotransplant basis donor pig, to be suitble to various organs
The exploitation of transplantation donor pig is prepared.
In step 3), the fetus of gestation is taken out to the editor's situation that can identify related gene, is the gene editing of next step
Strategy provides heterograft basis donor pig cell system.
Beneficial effects of the present invention:
The invention discloses a kind of construction method of xenotransplant basis donor pig, this method can move to solve Xenogeneic organ
The common problems such as the immunology incompatibility of the transplanting of plant and functional disorder provide base support, are suitble to difference thin to develop
The research of xenotransplantation donors pig of born of the same parents, tissue, organ are laid a good foundation, and are really effectively suitble to various cells, group to exploitation
Knit, the donor pig of organ xenotransplantation is of great significance, promote the research and development process of xenotransplant.
Detailed description of the invention
Fig. 1 is flow chart of the invention.
Specific embodiment
Embodiment 1
A kind of construction method of xenotransplant basis donor pig, specific operation process sequentially include the following steps:
1) it is fastened in the pig fibroblast of porcine endogenous retrovirus inactivation and knocks out GGTA1, CMAH, B4GalNT2 gene
On the basis of pig fibroblast, GGTA1, CMAH, B4GalNT2 tri- is knocked out using CRISPR/Cas9 gene technology
A gene obtains the pig fibroblast that tri- gene of GTKO/CMAHKO/B4GalNT2KO knocks out simultaneously;
2) it is fastened in the pig fibroblast of GTKO/CMAHKO/B4GalNT2KO modification and pinpoints insertion hCD55/hCD59/ again
Tri- humanization modifiers of hCD46
On the basis of tri- gene modification of GTKO/CMAHKO/B4GalNT2KO, then pinpoint insertion hCD55, hCD59, hCD46 tri-
A humanization modifier, obtain six gene modification of GTKO/CMAHKO/B4GalNT2KO/hCD55/hCD59/hCD46 pig at
Fibrocyte system;
3) body-cell neucleus transplanting and embryo transfer
Using somatic cell nuclear transfer technique, the GTKO/CMAHKO/B4GalNT2KO/hCD55/ that will be obtained through transfection screening
Six gene cell system of hCD59/hCD46 carries out body-cell neucleus transplanting, and the modification feelings of fetus identification gene are taken out when gestation 30 days
Condition is separately cultured and establishes six gene modification xenotransplantation donors pig fibroblasts, or is born when development of fetus is to 114d
Obtain xenotransplant basis donor pig individual.
Embodiment 2
A kind of construction method of xenotransplant basis donor pig, specific operation process sequentially include the following steps:
1) it is fastened in pig fibroblast while knocking out GGTA1, CMAH, B4GalNT2 gene
Existing pig fibroblast, on the basis of, using CRISPR/Cas9 gene editing technology simultaneously knock out GGTA1,
Tri- genes of CMAH, B4GalNT2 screen through transfection and obtain tri- gene of GTKO/CMAHKO/B4GalNT2KO while knocking out thin
Born of the same parents system carries out body-cell neucleus transplanting again, and fetus is taken out after gestation 30 days and identifies whether be positive, acquisition GTKO/CMAHKO/
Tri- gene knock-out pig fetal fibroblast cell line of B4GalNT2KO;
3) GTKO/CMAHKO/B4GalNT2KO modification pig fibroblast fasten pinpoint again insertion hCD55, hCD59,
Tri- humanization modifiers of hCD46
On the basis of the porcine fetus fibroblasts system of, tetra- gene modification of GTKO/CMAHKO/B4GaINT2KO, then pinpoint slotting
Enter tri- humanization modifiers of hCD55, hCD59, hCD46, is screened through transfection and obtain PERVKO/GTKO/CMAHKO/
The cell line of six gene modification of B4GalNT2KO/hCD55/hCD59/hCD46;
4) body-cell neucleus transplanting and embryo transfer
Using somatic cell nuclear transfer technique, the GTKO/CMAHKO/B4GalNT2KO/hCD55/hCD59/ that above-mentioned screening is obtained
Six gene cell system of hCD46 carries out body-cell neucleus transplanting, and the modification situation of fetus identification gene is taken out when gestation, is separately cultured
Six gene modification xenotransplantation donors pig fibroblasts are established, or obtain xenotransplant when development of fetus to birth
Basic donor pig individual.
Utilize the common problem being directed in xenotransplant in embodiment, the xenotransplant basis donor of building
Pig can accelerate research and development process of the pig as xenotransplant.Meanwhile on the basis of xenotransplant basis donor pig
On, different gene editing strategies can be taken to carry out target gene for different cells, tissue, organ xenotransplantation's scheme
Modification greatly will be saved screening time and save the investment of experiment fees, developed to the method modified using the assortment of genes
Really effective xenotransplant donor pig has great importance, and promotes the research and development process of heterograft industrialization.
Finally, it is stated that preferred embodiment above is only used to illustrate the technical scheme of the present invention rather than limits, although logical
It crosses above preferred embodiment the present invention is described in detail, however, those skilled in the art should understand that, can be
Various changes are made to it in form and in details, without departing from claims of the present invention limited range.
Claims (1)
1. a kind of construction method of xenotransplant basis donor pig, it is characterised in that: specific steps are as follows:
1) cause the gene of antigen-antibody immunological rejection in knock-out pig genome
On the basis of pig fibroblast, GGTA1, CMAH, B4GalNT2 tri- is knocked out using CRISPR/Cas9 gene technology
A specific gene;
2) fixed point insertion tri- humanization modifiers of hCD55, hCD59, hCD46
On the basis of tri- gene modification of GTKO/CMAHKO/B4GalNT2KO, then pinpoint insertion hCD55, hCD59, hCD46 tri-
A humanization modifier obtains what six gene of GTKO/CMAHKO/B4GalNT2KO/hCD55/hCD59/hCD46 was modified jointly
Pig fibroblast;
3) body-cell neucleus transplanting and embryo transfer
Using somatic cell nuclear transfer technique, the GTKO/CMAHKO/B4GalNT2KO/hCD55/ that will be obtained through transfection screening
Six gene cell system of hCD59/hCD46 carries out body-cell neucleus transplanting, and the volume of fetus identification fetus related gene is taken out when gestation
Situation is collected, is separately cultured and establishes six gene heterograft basis donor pig fibroblasts, or when development of fetus to when being born
Obtain xenotransplant basis donor pig;
4) continuous clone technology is utilized, by the heterograft basis donor pig fetus of six gene modifications of above-mentioned acquisition at fiber finer
Born of the same parents are to carry out body-cell neucleus transplanting and embryo transfer, and batch obtains xenotransplant basis donor pig, to be suitble to various organs
The exploitation of transplantation donor pig is prepared.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910497791.6A CN110373390A (en) | 2019-06-10 | 2019-06-10 | A kind of construction method of xenotransplant basis donor pig |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910497791.6A CN110373390A (en) | 2019-06-10 | 2019-06-10 | A kind of construction method of xenotransplant basis donor pig |
Publications (1)
Publication Number | Publication Date |
---|---|
CN110373390A true CN110373390A (en) | 2019-10-25 |
Family
ID=68250018
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201910497791.6A Pending CN110373390A (en) | 2019-06-10 | 2019-06-10 | A kind of construction method of xenotransplant basis donor pig |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN110373390A (en) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107249318A (en) * | 2014-12-10 | 2017-10-13 | 明尼苏达大学董事会 | For cell, tissue and the organ of the genetic modification for treating disease |
CN108588123A (en) * | 2018-05-07 | 2018-09-28 | 南京医科大学 | CRISPR/Cas9 carriers combine the application in the blood product for preparing gene knock-out pig |
-
2019
- 2019-06-10 CN CN201910497791.6A patent/CN110373390A/en active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107249318A (en) * | 2014-12-10 | 2017-10-13 | 明尼苏达大学董事会 | For cell, tissue and the organ of the genetic modification for treating disease |
CN108588123A (en) * | 2018-05-07 | 2018-09-28 | 南京医科大学 | CRISPR/Cas9 carriers combine the application in the blood product for preparing gene knock-out pig |
Non-Patent Citations (1)
Title |
---|
KONRAD FISCHER ET AL.: "Efficient production of multi-modified pigs for xenotransplantation by ‘combineering’, gene stacking and gene editing", 《SCIENTIFIC REPORTS》 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102140438A (en) | In-vitro culturing method for porcine skeletal muscle satellite cell (SMSC) | |
CN105177044B (en) | The method for obtaining lymthoma miniature pig disease model by knocking out P53 gene | |
CN102051344B (en) | Human osteosarcoma cell line group and mouse in-vivo transplantation model | |
CN103725710B (en) | One oneself can delete free carrier and application thereof | |
CN110373391A (en) | A kind of construction method of suitable cardiac xenograft donor pig | |
CN102643778A (en) | Method for separating, culturing and identifying primary hepatic cells of livestock and fowl | |
CN102191217A (en) | Method for inducing differentiation from human umbilical cord mesenchymai stem cells (hucMSCs) into neural cells | |
CN101372682B (en) | Construction method of Epinephelus fuscoguttatus fin cell line | |
CN103756952A (en) | Establishment and application method of ovary cell line of cynoglossus semilaevis | |
CN109392843A (en) | Oophoroma Transplanted tumor model and application are constructed based on organoid method | |
CN109997787B (en) | Method for breeding rat with non-alcoholic steatohepatitis transformed into hepatocellular carcinoma and application | |
CN110373389A (en) | A kind of construction method of the tissue xenotransplantation donors pig such as suitable islet cells and skin | |
CN109642210A (en) | A kind of manufacturing method of kidney | |
Liu et al. | Global trends of stem cell precision medicine research (2018–2022): A bibliometric analysis | |
CN110373390A (en) | A kind of construction method of xenotransplant basis donor pig | |
CN105219701B (en) | One boar portal vein week liver cell or vena hepatica week liver cell separation method and application | |
CN104818240B (en) | A kind of extracorporeal culturing method of Mouse Oviductal epithelial cell | |
CN101892286B (en) | Melanocyte bioactivity detection and personalized culture methods | |
CN103952441B (en) | The construction method of 1.3 copy C genotype HBV transgenic mices | |
CN103674653B (en) | A kind of creep plate method of primordial germ cell | |
CN110373392A (en) | A kind of construction method of suitable kidney xenotransplantation donors pig | |
CN104789596B (en) | A kind of production method of autosomal dominant polycystic kidney disease gene mutation pig and its application | |
CN106834207A (en) | A kind of Shelled Turtle Trionyx Sinensis gonad cell is separated and extracorporeal culturing method | |
CN104818247A (en) | Culture method and application of mesenchymal stem cell | |
CN105755047A (en) | Method for obtaining cloned pigs with modified genes through continuous cloning |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |